APC Anti-Human CD274/PD-L1 Antibody[29E.2A3]

APC Anti-Human CD274/PD-L1 Antibody[29E.2A3]

The APC Anti-Human CD274/PD-L1 Antibody[29E.2A3] is a cutting-edge immunological tool designed to specifically target and detect the CD274/PD-L1 protein in human samples. This antibody is conjugated with APC (Allophycocyanin), a highly stable and bright fluorochrome, enabling efficient and reliable flow cytometry analysis. With its exceptional specificity and sensitivity, this antibody provides researchers with a valuable tool for studying the expression and regulation of CD274/PD-L1, a critical immune checkpoint molecule involved in immune evasion and tumor progression.

This antibody, clone 29E.2A3, has been extensively validated and characterized for its high affinity and selectivity towards CD274/PD-L1. It recognizes the extracellular domain of CD274/PD-L1, allowing for the detection of both membrane-bound and soluble forms of the protein. The APC conjugation ensures minimal spectral overlap, enabling multiplexing with other fluorochromes for simultaneous detection of multiple targets. Moreover, this antibody has been optimized for use in various applications, including flow cytometry, immunohistochemistry, and immunofluorescence, providing researchers with flexibility in experimental design.

The APC Anti-Human CD274/PD-L1 Antibody[29E.2A3] offers exceptional performance and reliability, making it an indispensable tool for researchers studying immune checkpoint pathways and their role in cancer and autoimmune diseases. Its high specificity and sensitivity allow for accurate detection and quantification of CD274/PD-L1 expression in various sample types, including cell lines, primary cells, and tissues. With its robust performance and versatility, this antibody empowers researchers to gain deeper insights into the complex mechanisms underlying immune regulation and develop novel therapeutic strategies targeting CD274/PD-L1.